MOJO to be offered as an Oral Dissolvable Tablet (ODT) marketed to younger male demographic as an alternative to PRIME…
Strengthening its financial position with an infusion of new capital that will bolster its operations and practices, coast to coastNEW…
Dallas, Texas, May 28, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on…
The book is a collection of dozens of his essays about the human experience of practicing medicine. It covers various…
Dallas, TX, May 23, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on…
Tirzepatide, a dual GIP and GLP-1 receptor agonist (GIP/GLP-1 RA), is an antidiabetic medication used for the treatment of type…
Study represents a significant step in enhancing emergency response amid rising call volume and resource constraints.AUSTIN, Texas--(BUSINESS WIRE)--ESO, a leading…
Series A Funding Expedites Expansion Into Rural America to Help 98 Million Americans Living in Health Professional Shortage Areas (HPSAs)HOUSTON,…
Groundbreaking at-home pivotal trial of a much-anticipated therapeutic device is underwaySALT LAKE CITY--(BUSINESS WIRE)--#medicaldevices--PhotoPharmics, the leader in specialized phototherapy for…
King Faisal Specialist Hospital & Research Centre Leading Health Sector Transformation in Saudi Arabia King Faisal Specialist Hospital & Research…